Aflac Incorporated
NYSE:AFLInsurance - Life
-$1.34 today
- Market cap
- $61.96B
- Beta
- 0.61
- P/E (TTM)
- 12.7
- EPS (TTM)
- $9.04
- Dividend yield
- 2.07%
Volume 1.65M
Average 2.49M
AFL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Aflac IncorporatedNYSE: AFL
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AFL compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for AFL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding AFL) | — | — | — | 0.0% | |
Competitors are the stored peer set for AFL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 21.55B | 19.15B | 18.84B | 19.13B | 17.44B |
| Cost of Revenue | 0 | 0 | 0 | 12.31B | 10.65B |
| Gross Profit | 21.55B | 19.15B | 18.84B | 6.82B | 6.79B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 35.6% | 38.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 2.7B |
| Operating Expenses | 16.34B | 14.28B | 13.58B | 398M | 2.15B |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 910M |
| EBITDA | 5.21B | 4.87B | 5.26B | 6.42B | 5.56B |
| EBITDA Margin | 24.2% | 25.4% | 27.9% | 33.5% | 31.9% |
| Operating Income | 5.21B | 4.87B | 5.26B | 6.42B | 4.64B |
| Operating Margin | 24.2% | 25.4% | 27.9% | 33.5% | 26.6% |
| Interest Income | 0 | 0 | 0 | 0 | 973M |
| Interest Expense | 238M | 226M | 195M | 197M | 220M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (108M) |
| Income Before Tax | 5.21B | 4.87B | 5.26B | 6.42B | 4.53B |
| Pre-Tax Margin | 24.2% | 25.4% | 27.9% | 33.5% | 26.0% |
| Income Tax Expense | 977M | 451M | 603M | 974M | 887M |
| Net Income | 4.23B | 4.42B | 4.66B | 5.44B | 3.65B |
| Net Margin | 19.6% | 23.1% | 24.7% | 28.5% | 20.9% |
| EPS (Basic) | 6.42 | 6.96 | 7.81 | 9.68 | 6.86 |
| EPS (Diluted) | 6.39 | 6.93 | 7.78 | 9.63 | 6.83 |
| Weighted Avg Shares | 673.62M | 634.82M | 596.17M | 557.9M | 530.05M |
| Weighted Avg Shares (Diluted) | 676.73M | 637.66M | 598.75M | 565.02M | 532.02M |
Aflac Incorporated
NYSE:AFL
Intrinsic Alpha fair value
Locked
Current Price
$125.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.